Company Filing History:
Years Active: 2014-2025
Title: Suhrad G Banugaria: Innovator in Therapeutic Methods
Introduction
Suhrad G Banugaria is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of therapeutic methods, particularly in the context of enzyme replacement therapy and gene replacement therapy. With a total of 5 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
One of his latest patents is titled "Method of reducing titers of antibodies specific for a therapeutic agent." This invention relates to a method of treating patients undergoing enzyme replacement therapy (ERT) or other therapies that involve the administration of proteinaceous therapeutic agents. It also encompasses gene replacement therapy using non-viral or viral vectors. The invention aims to improve the administration of exogenous substances for potential therapeutic benefits, including DNA vaccines, siRNA, splice-site switching oligomers (SSOs), RNA-based nanoparticles (RNPs), and nanovaccines. The patent further details compounds and compositions suitable for use in these methods.
Career Highlights
Suhrad G Banugaria is affiliated with Duke University, where he continues to engage in innovative research and development. His work is characterized by a commitment to enhancing therapeutic modalities and improving patient outcomes.
Collaborations
He collaborates with esteemed colleagues, including Priya Kishnani and Dwight D Koeberl, who contribute to his research endeavors and help advance the field of therapeutic methods.
Conclusion
Suhrad G Banugaria's contributions to the field of therapeutic methods are significant and impactful. His innovative patents and collaborations reflect a dedication to improving medical treatments and patient care.